Riskpilot← Back to searchSign inGet full accessALFACARE AS
ASActiveOrg 98508643540 Heddalsvegen 11 Bygg 1, 3674 NotoddenWholesale of pharmaceutical and medical goods · NACE 4646Est. 200217 employees
Revenue 2024
NOK 54,7M
+14% vs 2023
EBITDA margin
7.1%
+18% vs 2023
Equity ratio
22.6%
Financial strength
Net profit 2024
NOK 2M
+59% vs 2023
| Revenue | NOK 54,7M | +14% |
| EBITDA | NOK 3,9M | +18% |
| Net profit | NOK 2M | +59% |
| Total assets | NOK 26M | -3% |
| Equity | NOK 5,9M | +7% |
| Employees | 17 | — |
Legal name
ALFACARE AS
Org number
985086435
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
21. november 2002
Share capital
NOK 1 688 770
Employees
17 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Kjøp og salg av helse- og sportsprodukter samt hva som står i en naturlig tilknytting til dette.
Address
40 Heddalsvegen 11 Bygg 1, 3674 Notodden
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2012 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 19 188 | 21 710 | 19 427 | 22 619 | 26 646 | 29 420 | 31 603 | 36 213 | 40 410 | 40 059 | 42 907 | 47 587 | 45 578 | 47 819 | 54 666 |
| Staff expenses | −3 047 | −3 227 | −3 180 | −4 161 | −5 455 | −5 306 | −6 804 | −6 611 | −6 300 | −6 748 | −5 962 | −6 072 | −7 771 | −7 013 | −8 425 |
| EBITDA | −136 | 929 | 934 | 1 306 | 1 025 | 1 559 | −46 | 1 187 | 1 589 | 1 115 | 2 766 | 3 696 | −1 314 | 3 264 | 3 865 |
| Depreciation & amort. | −44 | −66 | −122 | −146 | −141 | −93 | −88 | −82 | −64 | −92 | −93 | −407 | −882 | −907 | −947 |
| EBIT | −180 | 863 | 812 | 1 160 | 884 | 1 466 | −134 | 1 105 | 1 525 | 1 023 | 2 673 | 3 289 | −2 197 | 2 357 | 2 918 |
| Net financials | −881 | −552 | −603 | 0 | −421 | −646 | −128 | −802 | −663 | −621 | −263 | −287 | −450 | −722 | −319 |
| Profit before tax | −1 060 | 311 | 209 | 626 | 463 | 820 | −262 | 303 | 863 | 402 | 2 409 | 3 003 | −2 646 | 1 635 | 2 599 |
| Tax | −0 | −0 | 61 | 197 | 167 | 260 | −42 | 333 | 108 | 120 | 537 | 661 | −577 | 364 | 582 |
| Net profit | −1 060 | 311 | 148 | 429 | 296 | 560 | −220 | −29 | 754 | 282 | 1 873 | 2 341 | −2 069 | 1 271 | 2 017 |
| Item | 2008 | 2009 | 2010 | 2012 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 7 827 | 9 124 | 10 046 | 11 701 | 12 331 | 14 354 | 15 742 | 18 418 | 18 394 | 19 020 | 19 163 | 22 392 | 23 392 | 26 718 | 26 011 |
| Equity | −2 273 | −1 961 | −732 | 1 725 | 2 435 | 2 995 | 2 776 | 2 746 | 3 500 | 3 783 | 4 655 | 6 996 | 4 927 | 5 482 | 5 878 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 8 395 | 9 221 | 8 381 | 7 223 | 6 787 | 7 901 | 10 253 | 11 659 | 10 906 | 9 837 | 9 513 | 10 807 | 16 388 | 17 984 | 17 961 |
| Total debt | 10 100 | 11 085 | 10 779 | 9 976 | 9 897 | 11 359 | 12 967 | 15 672 | 14 893 | 15 237 | 14 508 | 15 395 | 18 465 | 21 237 | 20 134 |
EBITDA margin
7.1%
This company
15.8%
Market median
-55% vs market
20082024
Equity ratio
22.6%
This company
38.2%
Market median
-41% vs market
20082024
Return on equity
34.3%
This company
18.4%
Market median
+86% vs market
20082024
Net profit margin
3.7%
This company
8.1%
Market median
-54% vs market
20082024
Asset turnover
2.10×
This company
1.12×
Market median
+87% vs market
20082024
Debt / equity
3.43×
This company
0.62×
Market median
-453% vs market
20082024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Alfacare International As | Company | 91.1% | 91.1% | 2024 |
| Individual | 3.2% | 3.2% | 2024 | |
| Individual | 2.4% | 2.4% | 2022 | |
| Individual | 2.4% | 2.4% | 2024 | |
| Individual | 2.4% | 2.4% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Moxie As
ALFACARE AS Board members of ALFACARE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ansgar Gabrielsen | Board of Directors | 0 companies |
| Kai Roger Svendsen | Board of Directors | 0 companies |
| Nicolai Somdal | Board of Directors | 0 companies |
| Thorkild Haugan | Chairman | 0 companies |